참고문헌
- Surawicz TS, McCarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro Oncol 1999;1:14-25.
- Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 1994;120:817-20. https://doi.org/10.7326/0003-4819-120-10-199405150-00001
- Muhr C, Bergstrom K, Grimelius L, Larsson SG. A parallel study of the roentgen anatomy of the sella turcica and the histopathology of the pituitary gland in 205 autopsy specimens. Neuroradiology 1981;21:55-65. https://doi.org/10.1007/BF00342982
- Turner HE, Stratton IM, Byrne JV, Adams CB, Wass JA. Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation: a follow-up study. Clin Endocrinol (Oxf) 1999;51:281-4. https://doi.org/10.1046/j.1365-2265.1999.00865.x
- Brada M, Rajan B, Traish D, et al. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol (Oxf) 1993;38:571-8. https://doi.org/10.1111/j.1365-2265.1993.tb02137.x
- Grigsby PW, Stokes S, Marks JE, Simpson JR. Prognostic factors and results of radiotherapy alone in the management of pituitary adenomas. Int J Radiat Oncol Biol Phys 1988;15:1103-10. https://doi.org/10.1016/0360-3016(88)90191-5
- Snead FE, Amdur RJ, Morris CG, Mendenhall WM. Long-term outcomes of radiotherapy for pituitary adenomas. Int J Radiat Oncol Biol Phys 2008;71:994-8. https://doi.org/10.1016/j.ijrobp.2007.11.057
- Roberge D, Shenouda G, Souhami L. Pituitary. In: Halperin EC, Perez CA, Brady LW, editors. Perez and Brady's principles and practice of radiation oncology. 5th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2008. p. 751-64.
- Lee JY, Park KR, Kim HJ, Lee CI, Kim MS, Jung SH. Glioblastoma after radiotherapy for pituitary adenoma. J Korean Soc Ther Radiol Oncol 1999;17:287-92.
- Erridge SC, Conkey DS, Stockton D, et al. Radiotherapy for pituitary adenomas: long-term effi cacy and toxicity. Radiother Oncol 2009;93:597-601. https://doi.org/10.1016/j.radonc.2009.09.011
- Sasaki R, Murakami M, Okamoto Y, et al. The efficacy of conventional radiation therapy in the management of pituitary adenoma. Int J Radiat Oncol Biol Phys 2000;47:1337-45. https://doi.org/10.1016/S0360-3016(00)00503-4
- Tsang RW, Brierley JD, Panzarella T, Gospodarowicz MK, Sutcliffe SB, Simpson WJ. Role of radiation therapy in clinical hormonally-active pituitary adenomas. Radiother Oncol 1996;41:45-53. https://doi.org/10.1016/S0167-8140(96)91807-1
- Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81. https://doi.org/10.1080/01621459.1958.10501452
- Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
- Popovic EA, Vattuone JR, Siu KH, Busmanis I, Pullar MJ, Dowling J. Malignant prolactinomas. Neurosurgery 1991;29:127-30. https://doi.org/10.1227/00006123-199107000-00023
- Ciric I, Mikhael M, Stafford T, Lawson L, Garces R. Transsphenoidal microsurgery of pituitary macroadenomas with long-term follow-up results. J Neurosurg 1983;59:395-401. https://doi.org/10.3171/jns.1983.59.3.0395
- Gittoes NJ, Bates AS, Tse W, et al. Radiotherapy for nonfunction pituitary tumours. Clin Endocrinol (Oxf) 1998;48:331-7. https://doi.org/10.1046/j.1365-2265.1998.00393.x
- Greenman Y, Ouaknine G, Veshchev I, Reider G II, Segev Y, Stern N. Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth. Clin Endocrinol (Oxf) 2003;58:763-9. https://doi.org/10.1046/j.1365-2265.2003.01784.x
- Hughes MN, Llamas KJ, Yelland ME, Tripcony LB. Pituitary adenomas: long-term results for radiotherapy alone and post-operative radiotherapy. Int J Radiat Oncol Biol Phys 1993;27:1035-43. https://doi.org/10.1016/0360-3016(93)90520-6
- McCord MW, Buatti JM, Fennell EM, et al. Radiotherapy for pituitary adenoma: long-term outcome and sequelae. Int J Radiat Oncol Biol Phys 1997;39:437-44. https://doi.org/10.1016/S0360-3016(97)00335-0
- Colin P, Jovenin N, Delemer B, et al. Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients. Int J Radiat Oncol Biol Phys 2005;62:333-41. https://doi.org/10.1016/j.ijrobp.2004.09.058
- Brada M, Burchell L, Ashley S, Traish D. The incidence of cerebrovascular accidents in patients with pituitary adenoma. Int J Radiat Oncol Biol Phys 1999;45:693-8. https://doi.org/10.1016/S0360-3016(99)00159-5
- Ono Y, Maehara F. Complication of irradiation in brain tumors. Gan No Rinsho 1989;35:1347-53.
- Stewart FA, Hoving S, Russell NS. Vascular damage as an underlying mechanism of cardiac and cerebral toxicity in irradiated cancer patients. Radiat Res 2010;174:865-9. https://doi.org/10.1667/RR1862.1
- Jagannathan J, Sheehan JP, Pouratian N, Laws ER Jr, Steiner L, Vance ML. Gamma knife radiosurgery for acromegaly: outcomes after failed transsphenoidal surgery. Neurosurgery 2008;62:1262-9. https://doi.org/10.1227/01.neu.0000333297.41813.3d
- Jezkova J, Marek J, Hana V, et al. Gamma knife radiosurgery for acromegaly: long-term experience. Clin Endocrinol (Oxf) 2006;64:588-95. https://doi.org/10.1111/j.1365-2265.2006.02513.x
- Losa M, Gioia L, Picozzi P, et al. The role of stereotactic radiotherapy in patients with growth hormone-secreting pituitary adenoma. J Clin Endocrinol Metab 2008;93:2546-52. https://doi.org/10.1210/jc.2008-0135
- Petit JH, Biller BM, Coen JJ, et al. Proton stereotactic radiosurgery in management of persistent acromegaly. Endocr Pract 2007;13:726-34. https://doi.org/10.4158/EP.13.7.726
- Aghi MK, Petit J, Chapman P, et al. Management of recurrent and refractory Cushing's disease with reoperation and/or proton beam radiosurgery. Clin Neurosurg 2008;55:141-4.
- Rush S, Cooper PR. Symptom resolution, tumor control, and side effects following postoperative radiotherapy for pituitary macroadenomas. Int J Radiat Oncol Biol Phy 1997;37:1031-4. https://doi.org/10.1016/S0360-3016(96)00586-X
- Dekkers OM, van der Klaauw AA, Pereira AM, et al. Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 2006;91:3364-9. https://doi.org/10.1210/jc.2006-0003
피인용 문헌
- Characteristics of Acromegaly in Korea with a Literature Review vol.28, pp.3, 2011, https://doi.org/10.3803/enm.2013.28.3.164
- Excess Mortality Associated With Hypopituitarism in Adults: A Meta-Analysis of Observational Studies vol.100, pp.4, 2011, https://doi.org/10.1210/jc.2014-3787
- Effective time window in reducing pituitary adenoma size by gamma knife radiosurgery vol.18, pp.4, 2015, https://doi.org/10.1007/s11102-014-0603-8
- Long-term Outcome After Fractionated Radiotherapy for Pituitary Adenoma: The Curse of the Secretory Tumor vol.39, pp.1, 2011, https://doi.org/10.1097/coc.0000000000000014
- Long-term outcomes of surgery and radiotherapy for secreting and non-secreting pituitary adenoma vol.34, pp.2, 2011, https://doi.org/10.3857/roj.2016.01683
- Fractionated Stereotactic Radiotherapy for Pituitary Adenomas vol.79, pp.3, 2011, https://doi.org/10.1227/neu.0000000000001155
- Management of nonfunctioning pituitary tumors: radiotherapy vol.21, pp.2, 2018, https://doi.org/10.1007/s11102-018-0868-4
- Deferred Radiotherapy After Debulking of Non-functioning Pituitary Macroadenomas: Clinical Outcomes vol.8, pp.None, 2011, https://doi.org/10.3389/fonc.2018.00660
- Recurrent non-functioning pituitary adenomas: a review on the new pathological classification, management guidelines and treatment options vol.20, pp.10, 2011, https://doi.org/10.1007/s12094-018-1868-6
- Radiomics Approach for Prediction of Recurrence in Non-Functioning Pituitary Macroadenomas vol.10, pp.None, 2011, https://doi.org/10.3389/fonc.2020.590083
- Current perspectives on recurrent pituitary adenoma: The role and timing of surgery vs adjuvant treatment vol.92, pp.2, 2011, https://doi.org/10.1111/cen.14127
- Prediction of recurrence in solid nonfunctioning pituitary macroadenomas: additional benefits of diffusion-weighted MR imaging vol.132, pp.2, 2011, https://doi.org/10.3171/2018.10.jns181783